Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- Incidence of driver gene abnormalities
研究概览
简要总结
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
详细描述
This trial is a prospective non-interventional observational study. The Chinese patients with lymphoma were included and the study data on driver gene abnormalities, demographic characteristics, clinicopathological characteristics and treatment were collected to evaluate the relevance of efficacy and disease prognosis.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed as lymphoma (according to WHO 2017 classification criteria)
- •Life expectancy no less than 3 months
- •Agreeing to sign the written informed consents
排除标准
- •Other malignant tumor history or active malignant tumor need be treated
- •Researchers determine unsuited to participate in this trial
结局指标
主要结局
Incidence of driver gene abnormalities
时间窗: from the day of the first patient was included to the date of the end of this trial, assessed up to 36 months
the incidence of driver gene abnormalities by fixed gene testing technology
次要结局
- objective response rate(from the date of the first patient was included to the date of the end of this trial, assessed up to 36 months)
- 5-year overall survival(from the date of the first patient was included to the date of the end of this trial, assessed up to 5 years)
- Clinicopathological Characteristics(from the date of the first patient was included to the date of the end of this trial, assessed up to 36 months)
研究者
Yanyan Liu
Director
Henan Cancer Hospital
